Insulin glargine, recombinant Subcutaneous and NovoLog PenFill
Determining the interaction of Insulin glargine, recombinant Subcutaneous and NovoLog PenFill and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Novoseven
- Insulin glargine, recombinant Subcutaneous-NovoSeven RT
- Insulin glargine, recombinant Subcutaneous-NovoSeven RT with MixPro injection
- Insulin glargine, recombinant Subcutaneous-Novothyrox
- Insulin glargine, recombinant Subcutaneous-Noxafil
- Insulin glargine, recombinant Subcutaneous-Noxafil (Posaconazole Delayed-Release Tablets)
- NovoLog PenFill-Insulin glulisine
- NovoLog PenFill-Insulin Glulisine (Cartridges and Pens)
- NovoLog PenFill-Insulin Glulisine (Vials)
- NovoLog PenFill-Insulin glulisine Subcutaneous
- NovoLog PenFill-Insulin human inhaled Inhalation
- NovoLog PenFill-Insulin human regular Injection